Bullous erythema multiforme post Corbevax anti-COVID-19 vaccine: case report.
How to Cite
Dave M., Mehta H., Nimbark D. 2022. Bullous erythema multiforme post Corbevax anti-COVID-19 vaccine: case report. Eur. J. Pediat. Dermatol. 32 (4):218-21. 10.26326/2281-96220.127.116.113.
Vaccination against COVID-19 is key to reducing the impact of the disease. However, both COVID-19 and its vaccination can cause skin reactions. There are studies showing a link between erythema multiforme and COVID-19 infection; in some cases erythema multiforme can follow the anti-COVID-19 vaccination. The current report describes a case of bullous erythema multiforme that developed in a teenager after the Corbevax vaccine.
vaccine, COVID 19, erythema multiforme